Drug Price Trends for TUSSIN

Average Pharmacy Cost for TUSSIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
TUSSIN CF COUGH-COLD SYRUP	24385-0904-26	0.02082	ML	2025-03-19
TUSSIN CF MAX SEVERE M-S COLD	70000-0623-01	0.02332	ML	2025-03-19
TUSSIN DM 400-20 MG/20 ML LIQ	70000-0628-02	0.01762	ML	2025-03-19
TUSSIN MUCUS-CONG 200 MG/10 ML	00113-2061-26	0.02313	ML	2025-02-19
TUSSIN CF COUGH-COLD SYRUP	24385-0904-26	0.02102	ML	2025-02-19
TUSSIN DM 400-20 MG/20 ML LIQ	70000-0628-02	0.01758	ML	2025-02-19
TUSSIN CF MAX SEVERE M-S COLD	70000-0623-01	0.02382	ML	2025-02-19

Market Analysis and Price Projections for Tussin DM

Market Overview

Tussin DM, a cough syrup containing dextromethorphan and guaifenesin, operates within the broader cough syrup and respiratory medications market. Here’s a detailed analysis of the market trends, drivers, and price projections relevant to Tussin DM.

Global Cough Syrup Market

The global cough syrup market is expected to grow significantly, driven by increasing respiratory problems and the availability of over-the-counter (OTC) medications. The market is projected to reach $7.8 billion by 2026, growing at a CAGR of 5.8% during the forecast period[5].

Segmentation and Market Share

Product Type

The cough syrup market is segmented into cough suppressants, combination medications, and expectorants. Cough suppressants, which include dextromethorphan-based products like Tussin DM, hold the highest market share. This segment is expected to continue its dominance due to the widespread availability of dextromethorphan at medical stores and pharmacies[5].

Age Group

The adult segment is anticipated to garner the highest growth rate, driven by the increasing geriatric population and rising respiratory problems among adults. However, it is crucial to note that pediatric use of OTC cough syrups like Tussin DM should be strictly under medical supervision[5].

Distribution Channel

Retail pharmacies dominate the distribution channel for cough syrups, including Tussin DM, with a significant market share. Online pharmacies are also gaining traction, but retail pharmacies remain the primary point of purchase[5].

Regional Analysis

North America

North America, particularly the United States, is a key market for cough suppressants like Tussin DM. The region benefits from frequent FDA approvals for new cough suppressant drugs, which drives market growth. For instance, approvals such as the one for Mucinex DM Maximum Strength in 2018 have contributed to the market's expansion[1].

Asia-Pacific

The Asia-Pacific region is expected to witness significant growth due to increasing government initiatives, rising healthcare facilities, and a large population pool. This region is anticipated to continue its dominance in the cough syrup market during the forecast period[5].

Price Projections and Affordability

Current Pricing

The cost for Tussin DM oral liquid is around $11 for a supply of 118 milliliters, depending on the pharmacy. Generic versions are also available, which can be priced similarly or slightly lower[4].

Market Dynamics

The affordability of OTC medications like Tussin DM is a significant driver of market growth. These medications are generally cheaper than prescription or other respiratory medications, making them an attractive option for budget-conscious consumers[2].

Drivers and Restraints

Drivers

• Increasing Prevalence of Respiratory Conditions: The rising prevalence of cough-related conditions such as the common cold, flu, bronchitis, and allergies drives the demand for cough medications like Tussin DM[3].
• Growing Consumer Awareness and Self-Medication: Increased access to healthcare information and self-medication practices have led to higher demand for OTC cough suppressants[3].
• Healthcare Infrastructure: Strong healthcare facilities and rising research activities in regions like North America and Asia-Pacific support market growth[3].

Restraints

• Stringent Regulations: Regulatory changes, such as the reclassification of codeine as a prescription-only medicine in Australia, can affect the market growth of cough suppressants[1].
• Misuse and Abuse: The potential for misuse and abuse of cough syrups, particularly those containing dextromethorphan, can lead to stricter regulations and impact market growth[5].

Key Players and Strategic Moves

Key players in the market are involved in strategic mergers, partnerships, and licensing agreements to develop and commercialize novel cough suppressant drugs. For example, Tris Pharma Inc. partnered with Pfizer Consumer Healthcare to commercialize extended-release dextromethorphan cough syrup under the Robitussin brand[1].

Consumer Preferences and Brand Awareness

Pharmaceutical companies focus on promoting the effectiveness and ease of use of OTC expectorants and cough suppressants. Brand awareness and targeted marketing play a significant role in driving consumer preference towards these products, including Tussin DM[2].

Impact of COVID-19

The COVID-19 pandemic has had a significant impact on the demand for respiratory medications, including cough syrups. The initial outbreak led to a surge in demand for OTC expectorants and cough suppressants as people sought relief from respiratory symptoms associated with COVID-19. This trend is expected to continue as post-COVID-19 complications like lung fibrosis and COPD become more prevalent[2].

Key Takeaways

• The global cough syrup market, including products like Tussin DM, is expected to grow significantly due to increasing respiratory problems and the availability of OTC medications.
• North America and Asia-Pacific are key regions driving market growth.
• Affordability and consumer awareness are major drivers of the market.
• Regulatory changes and potential misuse can act as restraints.
• Strategic partnerships and brand awareness are crucial for market success.

Frequently Asked Questions (FAQs)

1. What is the expected growth rate of the global cough syrup market?

The global cough syrup market is expected to grow at a CAGR of 5.8% during the forecast period, reaching $7.8 billion by 2026[5].

2. Which segment dominates the cough syrup market?

Cough suppressants, which include products like Tussin DM, dominate the market due to their widespread availability and high demand[5].

3. What are the key drivers of the Tussin DM market?

Key drivers include the increasing prevalence of respiratory conditions, growing consumer awareness, and the affordability of OTC medications[2][3].

4. How has the COVID-19 pandemic impacted the market for cough syrups like Tussin DM?

The pandemic has led to a surge in demand for OTC expectorants and cough suppressants due to the need for relief from respiratory symptoms associated with COVID-19[2].

5. What are the potential restraints for the Tussin DM market?

Stringent regulations and the potential for misuse and abuse of cough syrups are significant restraints for the market[1][5].

Sources:

1. Coherent Market Insights - Cough Suppressant Drugs Market - Price, Size, Share & Growth
2. Mordor Intelligence - Expectorant Drugs Market Size & Share Analysis
3. Data Bridge Market Research - Global Dextromethorphan Market – Industry Trends and Forecast to 2030
4. Drugs.com - Tussin DM Prices, Coupons, Copay Cards & Patient Assistance
5. KBV Research - Cough Syrup Market Size, Trends & Growth Forecast 2020-2026